How a Phase II Biotech Used Copilot Studio Agents to Speed eCTD Drafting

How a Phase II Biotech Used Copilot Studio Agents to Speed eCTD Drafting

1. Problem / Context

A Phase II/III biotech with roughly $90M in revenue faced a familiar bottleneck: producing high‑quality eCTD content quickly, consistently, and audit‑ready with a lean regulatory operations team. Subject matter experts (SMEs) were distributed across clinical, nonclinical, and CMC functions, while documents lived across SharePoint and a Quality Management System (QMS). Authoring Module 2 summaries demanded meticulous cross‑referencing to source data, rigorous template adherence, and tight version control—under both EMA and FDA oversight.

The reality for mid‑market biotechs is that every submission sprint competes with ongoing trials, vendor management, and inspections. Without automation that understands documents and preserves traceability, teams either accept long drafting cycles or risk non‑compliant shortcuts. This organization chose a different path: governed, agentic AI built with Copilot Studio to accelerate drafting while strengthening compliance.

2. Key Definitions & Concepts

• eCTD Module 2: High‑level summaries (Quality Overall Summary, Nonclinical Overview/Summary, Clinical Overview/Summary) that synthesize evidence from Modules 3–5 and other sources.
• Agentic AI: AI systems that can perceive, reason, act across tools, and request human input—moving beyond simple RPA by understanding content, citing sources, and coordinating workflows.
• Copilot Studio Agents: Configurable AI agents that connect to enterprise systems (e.g., SharePoint, QMS), apply policy‑governed prompts, produce draft content with citations, and orchestrate human‑in‑the‑loop steps.
• Traceable Reasoning: Every draft paragraph ties back to its source artifacts with links, timestamps, and version IDs—enabling SME verification and audit defensibility.

3. Why This Matters for Mid‑Market Regulated Firms

Mid‑market biotechs operate under intense regulatory scrutiny with constrained headcount and budgets. Delays in Module 2 drafting cascade into submission milestones. Rework from unclear lineage or template deviations burns SME cycles. Audit questions drive additional unplanned effort. A governed agentic approach helps by:

• Reducing manual assembly time while keeping SMEs in control.
• Enforcing template and style compliance early to prevent late‑stage rework.
• Capturing lineage and decisions so audit queries are faster to resolve.
• Preserving least‑privilege access and immutable logs for EMA/FDA‑ready evidence.

Kriv AI—a governed AI and agentic automation partner for the mid‑market—frames initiatives like this to balance speed with compliance, emphasizing data readiness, workflow orchestration, and auditability from day one.

4. Practical Implementation Steps / Roadmap

1. Connect to sources with least‑privilege access
   • Map SharePoint libraries for clinical, nonclinical, and CMC content.
   • Integrate QMS for controlled documents, procedures, and change logs.
   • Apply data loss prevention and role‑based permissions before any drafting.
2. Ingest templates and style guides
   • Load EMA/FDA Module 2 templates and sponsor style guides.
   • Codify section‑level constraints (e.g., 2.5 Clinical Overview vs. 2.7 Clinical Summary boundaries) and citation rules.
3. Design agents for document understanding and drafting
   • Retrieval: Agents pull the latest controlled documents and tagged evidence.
   • Drafting: Agents propose section paragraphs with inline citations and links back to source files/versions.
   • Validation: Agents check against templates, metadata, and terminology lists; flag missing references.
4. Human‑in‑the‑loop review and gating
   • SMEs receive proposed sections with side‑by‑side sources.
   • Reviewers accept, edit, or request rework; each action is captured with user, timestamp, and rationale.
   • Approval gates commit changes to QMS; snapshots versioned for traceability.
5. Change control and lineage capture
   • Every paragraph stores provenance: source doc IDs, sections, and hashes.
   • Variant comparisons highlight what changed, why, and who approved.
   • Immutable audit log supports inspections and sponsor QA.
6. Deployment and evaluation
   • Use Copilot Studio environments aligned to dev/test/prod.
   • Establish red‑team prompts and evaluation sets to test for policy violations and hallucinations.
   • Monitor output quality metrics and reviewer turnaround to guide tuning.

Concrete outcome from this rollout: drafting time fell by 40%, review cycles dropped by two, and audit queries decreased by 30% on the subsequent submission—achieved without expanding the regulatory ops team.

5. Governance, Compliance & Risk Controls Needed

• Governed prompt libraries: Standardize prompts and guardrails by section (e.g., 2.3, 2.4, 2.5) with change control and approval.
• Role‑based access control: Limit which libraries and QMS artifacts each agent can touch; log every access.
• Data boundaries: Prevent export of controlled content to non‑approved locations; encrypt at rest and in transit.
• Human oversight: Mandatory SME approval gates before content crosses submission milestones.
• Model risk management: Track model versions, prompt changes, and evaluation results; define rollback plans.
• Lineage and immutability: Preserve source links, version IDs, and hashes so every claim in Module 2 is defensible.
• Vendor lock‑in mitigation: Store lineage and drafts in open, exportable formats; avoid opaque proprietary state.

Kriv AI’s governance‑first approach emphasizes prompt standardization, lineage capture, approval workflows, and immutable audit logs—precisely the controls that prevent pilot projects from stalling or failing under inspection pressure.

6. ROI & Metrics

How the team measured impact:

• Cycle time: 40% reduction in Module 2 drafting time.
• Review velocity: Two fewer review cycles before sign‑off.
• Audit readiness: 30% fewer audit queries on the next submission.
• Rework rate: Track edits per paragraph and root‑cause (template violation, missing source, terminology).
• Throughput: Number of sections finalized per week per SME.
• Cost per submission: Blend internal hours and vendor costs; tie to efficiency gains.
• Payback modeling: Compare monthly time savings to implementation run‑rate; include compliance risk reduction as a qualitative benefit.

A simple payback example structure: If Module 2 historically required 300 SME hours and the new approach consistently saves 40%, that’s 120 hours back per cycle. Multiplying by fully loaded rates and the number of annual submissions frames budget impact without speculative claims.

7. Common Pitfalls & How to Avoid Them

• Uncontrolled model outputs: Use governed prompts, evaluation sets, and policy checks to prevent off‑template content.
• Poor traceability: Enforce paragraph‑level lineage and immutable logs; no content advances without provenance.
• Over‑automation: Keep SMEs in the loop with clear approval gates; agents propose, humans decide.
• Permissions sprawl: Apply least‑privilege access and periodic entitlement reviews.
• Version chaos: Snapshots at every gate and QMS‑backed versioning prevent “Which file is final?” fire drills.
• Pilot graveyard: Define success metrics, governance artifacts, and a production runway from the outset—Kriv AI helps teams translate pilots into durable operations.

30/60/90-Day Start Plan

First 30 Days

• Inventory Module 2 workflows, templates, and style guides; prioritize sections with the highest rework.
• Map SharePoint/QMS libraries, metadata, and permissions; close gaps in tagging and version control.
• Define governance boundaries: prompt library ownership, approval roles, data residency, and audit log retention.
• Establish metrics baseline (cycle time, review cycles, audit queries, rework rate) for pre/post comparison.

Days 31–60

• Implement a pilot in two Module 2 sections (e.g., 2.5 Clinical Overview, 2.7 Clinical Summary).
• Configure Copilot Studio agents for retrieval, drafting with citations, and template validation.
• Stand up human‑in‑the‑loop review with gated approvals and QMS snapshots.
• Run evaluation sets and red‑team prompts to test policy adherence and hallucination resistance.
• Begin weekly ROI tracking: time saved, edits per paragraph, blocked defects.

Days 61–90

• Scale to adjacent sections; standardize prompt libraries and terminology lists.
• Institute monitoring: lineage completeness, access logs, and reviewer turnaround SLAs.
• Update SOPs and training; formalize change control for prompts and models.
• Present results to leadership with before/after metrics and an expansion roadmap.

9. Industry-Specific Considerations

• Regulators: Align with EMA/FDA expectations for Module 2 clarity, consistency, and traceability.
• Part 11/Annex 11: Ensure electronic records, signatures, and audit trails meet validation and retention requirements.
• Terminology control: Harmonize CT, CMC, and nonclinical terminology to prevent cross‑section inconsistencies.
• Vendor ecosystem: Maintain clear boundaries with CROs and external authors; control access via governed sharing.

10. Conclusion / Next Steps

This Phase II biotech proved that agentic AI can speed eCTD drafting without sacrificing compliance. By connecting Copilot Studio agents to SharePoint and QMS, enforcing governed prompts and lineage, and keeping SMEs decisively in the loop, the team cut drafting time by 40%, reduced review cycles by two, and fielded 30% fewer audit queries on the very next submission.

If you’re exploring governed Agentic AI for your mid‑market organization, Kriv AI can serve as your operational and governance backbone—helping with data readiness, MLOps, and workflow orchestration so lean regulatory teams can move faster with confidence.